跳至主要内容
临床试验/PACTR201909600414183
PACTR201909600414183已完成2 期

Comparison between the Efficiency of Cinnarizine and Topiramate in the treatment of Vestibular Migraine

faculty of medicine menoufya university0 个研究点目标入组 72 人开始时间: 2019年1月7日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • A. At least five episodes with vestibular symptoms of moderate or severe intensity, each lasting 5 min to 72 h
  • B. Current or previous history of migraine with or without aura according to the International Classification of Headache Disorders (ICHD)
  • C. One or more migraine features with at least 50% of the vestibular episodes:
  • Headache with at least two of the following characteristics: one-sided location, pulsating quality, moderate or severe pain intensity, or aggravation by routine physical activity
  • Photophobia and phonophobia
  • Visual aura
  • D. Not better accounted for by another vestibular or ICHD diagnosis.

排除标准

  • age more than 60 years
  • age less than 18 years

研究者

发起方
faculty of medicine menoufya university

相似试验